Any new or unusual symptom after dosing. Because this compound has little or no human safety data, there is no established list of 'expected' effects to reassure you against — treat anything abnormal as a signal.
Stop at the first clearly abnormal reaction and reassess. Keep the vial and lot number in case you need to describe what you actually took.
Any severe or fast-worsening symptom — difficulty breathing, chest pain, fainting, severe pain — is a 911 call regardless of the compound.
Allergic reaction: hives, swelling of the lips, tongue or throat, wheezing or dizziness can escalate to anaphylaxis within minutes — call 911 immediately. Site infection: spreading redness, heat, swelling, pus or fever is not wait-and-see; an abscess or cellulitis can need drainage or IV antibiotics. Unverified product: grey-market vials are frequently mislabelled or contaminated, so a reaction may be to endotoxin or the wrong contents, not the named compound.
The decapeptide fragment of kisspeptin, the master upstream regulator of reproductive endocrinology. Signalling at KISS1R on hypothalamic GnRH neurons triggers GnRH release, and thereby LH and FSH. Loss-of-function mutations in KISS1R cause hypogonadotropic hypogonadism — which is how the pathway's necessity was established. It sits above the entire HPG axis.
A genuine and active academic research subject, principally at Imperial College London. Human studies have examined its role in reproductive physiology, hypothalamic amenorrhoea, IVF trigger protocols, and sexual-response neuroimaging. Human data exist, but as physiological investigation — not as an approved therapeutic.
Not FDA-approved. Investigational; used in academic research under appropriate oversight.
Short-term administration in supervised research settings has been well tolerated. Consequences of unsupervised or repeated administration on HPG axis regulation are not established — this is a master regulator, and perturbing it casually is not a small intervention.
Research only: IV boluses or infusions in supervised physiology studies. No therapeutic dose has been established.
Reported from clinical trials or FDA labelling as a matter of record. It is not a recommendation, and for unapproved compounds no dose has been shown safe or effective in humans.
Above is what was administered in trials or on FDA labels, reported as fact. We do not convert it into a personal protocol, calculate a dose for your body weight, or tell you what to inject or how to reconstitute it — that decision belongs with a licensed physician. See our editorial policy.
Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.